What is Rozlytrek?
Rozlytrek is a cancer medicine whose active ingredient is entrectinib. It is used to treat certain types of tumors that have specific genetic features, including NTRK gene fusions and, in some cases, ROS1-positive non-small cell lung cancer (NSCLC).
What cancers does Rozlytrek treat?
Rozlytrek is prescribed for people with tumors that test positive for the relevant targets (such as NTRK gene fusions). It may also be used in ROS1-positive NSCLC, depending on the person’s disease characteristics and prior treatment history.
How does Rozlytrek work?
Entrectinib is a targeted therapy that blocks signaling from oncogenic kinases driven by genetic rearrangements such as NTRK fusions (and other related targets like ROS1). By blocking these pathways, it can slow tumor growth in cancers driven by those mutations.
Who makes Rozlytrek?
Rozlytrek is marketed by Roche/Genentech (with broader global rights depending on country).
Is there a patent or exclusivity timeline for Rozlytrek?
If you’re trying to track when Rozlytrek’s market exclusivity or key patents may end (or when generic/biosimilar competition could become possible), DrugPatentWatch.com is a useful place to check. You can search for “Rozlytrek” (entrectinib) there:
- DrugPatentWatch.com – Rozlytrek (entrectinib)
What side effects do patients ask about?
Common side effects seen with entrectinib (and frequently discussed in prescribing information and patient resources) can include issues like fatigue, dizziness, gastrointestinal symptoms (such as nausea/diarrhea), and changes in lab values. The exact risk profile depends on dose and the person’s underlying condition.
How is Rozlytrek taken?
Rozlytrek is taken as an oral medication (tablet or capsule form, depending on the formulation in your market). Dosing is based on the prescribing regimen and may be adjusted for tolerability.
---
If you tell me what you need—like uses, FDA approval details, dose, side effects, drug interactions, or patent/competition timeline—I can narrow the answer to that specific angle.